
    
      The LEVANT I trial will enroll patients presenting with clinical evidence of claudication or
      critical limb ischemia and an angiographically significant lesion in the femoropopliteal
      arteries. Patients will be randomized to treatment with either the Lutonix Catheter or
      standard balloon angioplasty after predilation.
    
  